Fig. 2From: Non-specific irreversible 89Zr-mAb uptake in tumours: evidence from biopsy-proven target-negative tumours using 89Zr-immuno-PETIndividual Patlak linearization plots from the 89Zr-anti-CD20 study (A) and the 89Zr-CEA-IL2v study (B). neg = target-negative, pos = target-positiveBack to article page